MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)

Aptevo Therapeutics Inc. (APVO)

Aptevo Therapeutics Inc. (APVO)

Cash Flow
Quarterly Cash Flow Statement for the quarter ending in 2026-06-30
source: myfinsight.com
APVO Cash Flow Sankey DiagramSankey diagram visualizing APVO cash flow for the periodProceeds from issuance ofcommon stock and...$726K (-94.95%↓ Y/Y)Net cash provided byfinancing activities$726K (-94.95%↓ Y/Y)Increase (decrease) incash and cash...-$4,728K (-779.31%↓ Y/Y)Canceled cashflow$726K Prepaid expenses andother current assets-$457K (-66.79%↓ Y/Y)Accounts payable$272K Non-cash lease expense$270K Accrued expenses andother current...$157K Stock-based compensation$58K (241.18%↑ Y/Y)Depreciation andamortization$32K (-70.91%↓ Y/Y)Net cash used inoperating activities-$5,454K (60.10%↑ Y/Y)Canceled cashflow$1,246K Net loss-$6,356K (49.60%↑ Y/Y)Operating lease liability-$344K